missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Serpin C1/Antithrombin-III Rabbit anti-Human, Clone: 23, Novus Biologicals™
  7. 18204837

Serpin C1/Antithrombin-III Rabbit anti-Human, Clone: 23, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP2-89296-100UL

 View more versions of this product

Product Code. 18204837

  • € 552.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Serpin C1/Antithrombin-III Monoclonal specifically detects Serpin C1/Antithrombin-III in Human samples. It is validated for ELISA.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Serpin C1/Antithrombin-III
Monoclonal
Unconjugated
0.2 um filtered solution in PBS
Rabbit
Protein A purified
RUO
462
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG
ELISA
23
ELISA 1:5000-1:10000
AT3antithrombin-III, ATIIIantithrombin III, MGC22579, serine (or cysteine) proteinase inhibitor, clade C (antithrombin), member 1, serine-cysteine proteinase inhibitor clade C member 1, Serpin C1, serpin peptidase inhibitor, clade C (antithrombin), member 1
Recombinant Human Serpin C1/Antithrombin-III protein
100 μg
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.